NDC 78206-162

Renflexis

Infliximab

Renflexis is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Infliximab.

• Product ID: 78206-162_488396cb-243a-45bf-b936-fcde5dcdb465
• NDC: 78206-162
• Product Type: Human Prescription Drug
• Proprietary Name: Renflexis
• Generic Name: Infliximab
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2017-04-21
• Marketing Category: BLA /
• Application Number: BLA761054
• Labeler Name: Organon LLC
• Substance Name: INFLIXIMAB
• Active Ingredient Strength: 100 mg/1
• Pharm Classes: Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 78206-162-01

1 VIAL in 1 CARTON (78206-162-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99)

• Marketing Start Date: 2021-06-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Renflexis" or generic name "Infliximab"

NDC	Brand Name	Generic Name
0006-4305	Renflexis	infliximab
78206-162	Renflexis	infliximab
57894-160	INFLIXIMAB	INFLIXIMAB
57894-030	REMICADE	INFLIXIMAB